Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors

Pediatric Pulmonology

Volumn 43, Issue 2, 2008, Pages 200-202

  Brown, Sarah M N ^a   Padley, Simon ^a   Bush, Andrew ^a   Cummins, David ^a   Davidson, Simon ^a   Buchdahl, Roger ^b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b Hillingdon Hospital NHS Trust   (United Kingdom)

Author keywords

Child; Mycoplasma pneumonia; Thromboemboli

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLAVULANIC ACID; DALTEPARIN; HEPARIN; PROTEIN C;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EMPYEMA; FOLLOW UP; HEALTH STATUS; HUMAN; LUNG EMBOLISM; MALE; MYCOPLASMA PNEUMONIA; OXYGEN CONSUMPTION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; THROMBUS; ULTRASOUND;

ACTIVATED PROTEIN C RESISTANCE; ANTIBODIES, ANTIPHOSPHOLIPID; CHILD; HUMANS; MALE; PNEUMONIA, MYCOPLASMA; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 39449130841     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20739     Document Type: Article

References (10)

1. Revel-Vilk S, Massicotte P. Thromboembolic diseases of childhood. Blood Rev 2003;17:1-6.
2. Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics 2007;119:292-295.
3. Creagh MD, Roberts IF, Clark DJ, Preston FE. Familial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia. J Clin Pathol 1991;44:870-871.
4. Van Dyke DC, Eldadah MK, Bale JF Jr. Kramer M, Alexander R, Smith WL, Olivero W. Mycoplasma pneumoniae-induced cerebral venous thrombosis treated with urokinase. Clin Pediatr (Phila) 1992;31:501-504.
5. Joo CU, Kim JS, Han YM. Mycoplasma pneumoniae induced popliteal artery thrombosis treated with urokinase. Postgrad Med J 2001;77:723-724.
6. Bakshi M, Khemani C, Vishwanathan V, Anand RK. Mycoplasma pneumonia with antiphospholipid antibodies and a cardiac thrombus. Lupus 2006;15:105-106.
7. Rask O, Berntorp E, Ljung R. Risk factors for venous thrombosis in Swedish children and adolescents. Acta Paediatr 2005;94:717-722.
8. 2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism. Clin Chem 2005;51:545-552.
9. Male C, Mitchell L, Julian J, Vegh P, Joshua P, Adams M, David M, Andrew ME. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2001;97:844-849.
10. Miragliotta G, Fumarola D. Intravascular coagulation and Mycoplasma pneumoniae infection. Lancet 1988;1:243.